Results
1 -
10 of
128Pike Andy, Storer R. Ian, Owen Robert M., Armstrong Emma, Benn Caroline L., Bictash Magda, Cheung Kathy F. K., Costelloe Kathryn, Dardennes Emmanuel, Impey Emma, Milliken Philip H., Mortimer-Cassen Elisabeth, Pearce Hannah J..
The design, synthesis and evaluation of low molecular weight acidic sulfonamides as URAT1 inhibitors for the treatment of gout, Med. Chem. Commun., 2016 Storer R. Ian, Owen Robert M., Pike Andy, Benn Caroline L., Armstrong Emma, Blakemore David C., Bictash Magda, Costelloe Kathryn, Impey Emma, Milliken Philip H., Mortimer-Cassen Elisabeth, Pearce Hannah J., Pibworth Benjamin, Toschi Gianna.
The discovery and evaluation of diaryl ether heterocyclic sulfonamides as URAT1 inhibitors for the treatment of gout, Med. Chem. Commun., 2016 Arzneimittelinduzierte Symptome und Erkrankungen, Pflegehandbuch Arzneitherapie Clinical trials report, Current Rheumatology Reports Renal Excretions of Oxypurinol and Oxypurines ? Effects of Pyrazinamide, Probenecid and Benzbromarone, Purine and Pyrimidine Metabolism in Man VI Kombinierte Behandlung der Hyperurik??mie, Therapie und Prognose von Hyperurik??mie und Gicht Renal Excretion of Purine Bases ? Effects of Probenecid, Benzbromarone and Pyrazinamide, Purine and Pyrimidine Metabolism in Man VI Uricosuric effect of irtemazole in healthy subjects, Klinische Wochenschrift How Should we Treat Tophaceous Gout in Patients with Allopurinol Hypersensitivity?, Purine and Pyrimidine Metabolism in Man IX Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics, Arthritis Research & Therapy